XRF Scientific Inkomsten in het verleden

Verleden criteriumcontroles 4/6

XRF Scientific is de winst gegroeid met een gemiddeld jaarlijks percentage van 25.8%, terwijl de Machinery industrie de winst jaarlijks groeide met 25.8%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 18.1% per jaar. Het rendement op eigen vermogen van XRF Scientific is 17.1%, en het heeft een nettomarge van 14.8%.

Belangrijke informatie

25.8%

Groei van de winst

25.2%

Groei van de winst per aandeel

Machinery Groei van de industrie	29.3%
Inkomstengroei	18.1%
Rendement op eigen vermogen	17.1%
Nettomarge	14.8%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

Sep 19

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Aug 22

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Feb 01

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Oct 19

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

May 12

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Apr 21

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Oct 01

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

May 18

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

Apr 19

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25

Opbrengsten en kosten

Hoe XRF Scientific geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

ASX:XRF Opbrengsten, kosten en inkomsten (AUD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Jun 24	60	9	12
31 Mar 24	58	9	11
31 Dec 23	57	8	10
30 Sep 23	56	8	10
30 Jun 23	55	8	10
31 Mar 23	52	7	10
31 Dec 22	49	7	10
30 Sep 22	44	7	9
30 Jun 22	40	6	9
31 Mar 22	37	6	8
31 Dec 21	35	6	8
30 Sep 21	33	5	8
30 Jun 21	31	5	7
31 Mar 21	30	5	7
31 Dec 20	28	4	7
30 Sep 20	29	3	7
30 Jun 20	29	3	7
31 Mar 20	29	3	7
31 Dec 19	30	3	7
30 Sep 19	29	2	7
30 Jun 19	29	2	7
31 Mar 19	28	2	7
31 Dec 18	27	2	7
30 Sep 18	26	1	7
30 Jun 18	24	1	7
31 Mar 18	24	1	7
31 Dec 17	23	1	7
30 Sep 17	22	1	7
30 Jun 17	22	1	7
31 Mar 17	22	1	7
31 Dec 16	22	1	6
30 Sep 16	21	1	6
30 Jun 16	21	2	6
31 Mar 16	20	2	5
31 Dec 15	20	2	5
30 Sep 15	20	2	5
30 Jun 15	21	3	5
31 Mar 15	21	3	5
31 Dec 14	22	3	5
30 Sep 14	22	3	4
30 Jun 14	22	2	4
31 Mar 14	21	3	4
31 Dec 13	20	3	4

Kwaliteitswinsten: XRF heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (14.8%) XRF } zijn hoger dan vorig jaar (13.9%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van XRF is de afgelopen 5 jaar aanzienlijk gegroeid met 25.8% per jaar.

Versnelling van de groei: De winstgroei van XRF over het afgelopen jaar ( 15.6% ) ligt onder het 5-jarig gemiddelde ( 25.8% per jaar).

Winst versus industrie: De winstgroei XRF over het afgelopen jaar ( 15.6% ) overtrof de Machinery -sector -1.2%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 17.1% ) van XRF wordt als laag beschouwd.

XRF Scientific Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Full year 2024 earnings: EPS and revenues exceed analyst expectations

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

Recent updates

Price target increased by 8.0% to AU$1.75

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Full year 2024 earnings: EPS and revenues exceed analyst expectations

XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million.

Now 22% undervalued

Price target increased by 19% to AU$1.55

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 25% undervalued

Now 23% undervalued

Now 23% undervalued

Now 22% undervalued

Now 20% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Now 21% undervalued

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

New minor risk - Market cap size

Investor sentiment improves as stock rises 15%

Now 22% undervalued after recent price drop

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

New minor risk - Dividend sustainability

Full year 2023 earnings: EPS and revenues miss analyst expectations

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 19%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 18%

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Insufficient new directors

Now 21% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

Now 24% undervalued

Price target increased to AU$0.65

Insufficient new directors

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Upcoming dividend of AU$0.02 per share

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Price target increased to AU$0.46

Non-Executive Director recently bought AU$72k worth of stock

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued